Johnson & Johnson (Extended Hours)Johnson & Johnson (Extended Hours)Johnson & Johnson (Extended Hours)

Johnson & Johnson (Extended Hours)

No trades
See on Supercharts

Key facts today

The European Medicines Agency has accepted the marketing application for AVT05, a biosimilar of Johnson & Johnson's Simponi and Simponi Aria. The approval process is expected to finish in Q4 2025.
Brett Kay from Johnson & Johnson discussed using real-world evidence and health data to support vulnerable groups at Empower 2024.
Analyze the impactAnalyze the impact

About Johnson & Johnson


Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.